Oncogene

Home / Publications / Oncogene

Retraction Note: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin.

Oncogene

Damiano L, Stewart KM, Cohet N, Mouw JK, Lakins JN, Debnath J, Reisman D, Nickerson JA, Imbalzano AN, Weaver VM

Low lamin A levels enhance confined cell migration and metastatic capacity in breast cancer.

Oncogene

Bell ES, Shah P, Zuela-Sopilniak N, Kim D, Varlet AA, Morival JLP, McGregor AL, Isermann P, Davidson PM, Elacqua JJ, Lakins JN, Vahdat L, Weaver VM, Smolka MB, Span PN, Lammerding J

Oncogenic targeting of BRM drives malignancy through C/EBPß-dependent induction of a5 integrin.

Oncogene

Damiano L, Stewart KM, Cohet N, Mouw JK, Lakins JN, Debnath J, Reisman D, Nickerson JA, Imbalzano AN, Weaver VM

Biomechanical regulation of cell orientation and fate.

Oncogene

Lopez JI, Mouw JK, Weaver VM

Support Engineering Innovations at UCSF